Related references
Note: Only part of the references are listed.Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas
Jennifer Barrow et al.
NEURO-ONCOLOGY (2011)
Central nervous system penetration and enhancement of temozolomide activity in childhood medulloblastoma models by poly(ADP-ribose) polymerase inhibitor AG-014699
R. A. Daniel et al.
BRITISH JOURNAL OF CANCER (2010)
Pre-clinical and clinical evaluation of PARP inhibitors as tumour-specific radiosensitisers
C. Powell et al.
CANCER TREATMENT REVIEWS (2010)
Whole-Genome Profiling of Pediatric Diffuse Intrinsic Pontine Gliomas Highlights Platelet-Derived Growth Factor Receptor α and Poly (ADP-ribose) Polymerase As Potential Therapeutic Targets
Maryam Zarghooni et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Integrated Molecular Genetic Profiling of Pediatric High-Grade Gliomas Reveals Key Differences With the Adult Disease
Barbara S. Paugh et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
Andrew Tutt et al.
LANCET (2010)
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
M. William Audeh et al.
LANCET (2010)
Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology
Kimberly R. Porter et al.
NEURO-ONCOLOGY (2010)
Life with or without AIF
Emilie Hangen et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
The potential role and application of PARP inhibitors in cancer treatment
Anthony J. Chalmers
BRITISH MEDICAL BULLETIN (2009)
In vitro and In vivo Radiosensitization of Glioblastoma Cells by the Poly (ADP-Ribose) Polymerase Inhibitor E7016
Andrea L. Russo et al.
CLINICAL CANCER RESEARCH (2009)
Poly(Adenosine Diphosphate-Ribose) Polymerase-1 Expression in Cutaneous Malignant Melanomas as a New Molecular Marker of Aggressive Tumor
Bela Csete et al.
PATHOLOGY & ONCOLOGY RESEARCH (2009)
PARP1 Expression in Pediatric Central Nervous System Tumors
Valerie N. Barton et al.
PEDIATRIC BLOOD & CANCER (2009)
Poly(ADP-ribose) makes a date with death
James T. Heeres et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2007)
Pattern of recurrence in paediatric malignant glioma: an institutional experience
Sucheta J. Vaidya et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Poly(ADP-ribose) (PAR) polymer is a death signal
Shaida A. Andrabi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death
Seong-Woon Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Apoptosis-inducing factor triggered by poly(ADP-ribose) polymerase and bid mediates neuronal cell death after oxygen-glucose deprivation and focal cerebral ischemia
C Culmsee et al.
JOURNAL OF NEUROSCIENCE (2005)
Temozolomide pharmacodynamics in patients with metastatic melanoma: DNA damage and activity of repair enzymes 6-alkylguanine alkyltransferase and poly(ADP-ribose) polymerase-1
ER Plummer et al.
CLINICAL CANCER RESEARCH (2005)
Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor
SW Yu et al.
SCIENCE (2002)
Expression of poly(ADP-ribose) polymerase and distribution of poly(ADP-ribosyl)ation in glioblastoma and in a glioma multicellular tumour spheroid model
SB Wharton et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2000)
Share Paper
